KYinno Biotechnology Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 130

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $34.5M

  • Investors
  • 9

KYinno Biotechnology General Information

Description

Developer of oncology drugs intended to accelerate cancer drug discovery and development. The company offers immune treatments against cancer, antibody discovery workflows, engineered cellular systems, and next-generation kinase inhibitor design, dedicated to oncology drug discovery and customized product development, enabling these groups to progress their scientific programs effectively.

Contact Information

Website
www.kyinno.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • F2 Building, Yizhuang Biomedical Park
  • Number 88 Kechuang Six Street, Yizhuang Economic and Technological Development East Zone
  • Beijing, 101111
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • F2 Building, Yizhuang Biomedical Park
  • Number 88 Kechuang Six Street, Yizhuang Economic and Technological Development East Zone
  • Beijing, 101111
  • China
+86 010

KYinno Biotechnology Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KYinno Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 24-Feb-2025 $34.5M Completed Generating Revenue
4. Secondary Transaction - Private 03-Jan-2023 Completed Generating Revenue
3. Early Stage VC (Series A1) 24-Oct-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 29-Jan-2021 $7.86M $9M Completed Generating Revenue
1. Early Stage VC 10-Jul-2017 $1.18M $1.18M Completed Startup
To view KYinno Biotechnology’s complete valuation and funding history, request access »

KYinno Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of oncology drugs intended to accelerate cancer drug discovery and development. The company offers immune trea
Drug Discovery
Beijing, China
130 As of 2025

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

KYinno Biotechnology Competitors (1)

One of KYinno Biotechnology’s competitors is Horizon Discovery, a Formerly VC-backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Horizon Discovery Formerly VC-backed Cambridge, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

KYinno Biotechnology Patents

KYinno Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026145542-A1 Polypeptide and antibody containing same Pending 30-Dec-2024
AU-2025239846-A1 Polypeptide and use thereof in construction of bispecific antibody containing common light chain Pending 22-Mar-2024
JP-2026505866-A Polypeptide acting as a light chain and antibody containing the same Pending 15-Feb-2023
AU-2024221409-A1 Polypeptide and antibody containing same acting as light-chain Pending 15-Feb-2023
EP-4667489-A1 Polypeptide and antibody containing same acting as light-chain Pending 15-Feb-2023 C07K16/2803
To view KYinno Biotechnology’s complete patent history, request access »

KYinno Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KYinno Biotechnology Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing State-owned Capital Operation and Management Government Minority
BioTrack Capital Venture Capital Minority
China Everbright Asset Manager Minority
Renai Capital Corporate Venture Capital Minority
Yizhuang Guotou Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

KYinno Biotechnology FAQs

  • When was KYinno Biotechnology founded?

    KYinno Biotechnology was founded in 2017.

  • Where is KYinno Biotechnology headquartered?

    KYinno Biotechnology is headquartered in Beijing, China.

  • What is the size of KYinno Biotechnology?

    KYinno Biotechnology has 130 total employees.

  • What industry is KYinno Biotechnology in?

    KYinno Biotechnology’s primary industry is Drug Discovery.

  • Is KYinno Biotechnology a private or public company?

    KYinno Biotechnology is a Private company.

  • What is KYinno Biotechnology’s current revenue?

    The current revenue for KYinno Biotechnology is .

  • How much funding has KYinno Biotechnology raised over time?

    KYinno Biotechnology has raised $59M.

  • Who are KYinno Biotechnology’s investors?

    Beijing State-owned Capital Operation and Management, BioTrack Capital, China Everbright, Renai Capital, and Yizhuang Guotou are 5 of 9 investors who have invested in KYinno Biotechnology.

  • Who are KYinno Biotechnology’s competitors?

    Horizon Discovery is a competitor of KYinno Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process